ORG Wealth Partners LLC Sells 87 Shares of Zoetis Inc. (NYSE:ZTS)

ORG Wealth Partners LLC cut its position in shares of Zoetis Inc. (NYSE:ZTS) by 4.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,000 shares of the company’s stock after selling 87 shares during the quarter. ORG Wealth Partners LLC’s holdings in Zoetis were worth $326,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Darwin Wealth Management LLC purchased a new stake in Zoetis in the 3rd quarter worth about $31,000. First Personal Financial Services bought a new position in Zoetis in the 3rd quarter worth approximately $33,000. Capital Performance Advisors LLP purchased a new position in Zoetis in the 3rd quarter valued at approximately $33,000. Dunhill Financial LLC raised its holdings in Zoetis by 80.6% during the 3rd quarter. Dunhill Financial LLC now owns 168 shares of the company’s stock valued at $33,000 after acquiring an additional 75 shares during the period. Finally, Quarry LP lifted its position in shares of Zoetis by 273.2% during the second quarter. Quarry LP now owns 209 shares of the company’s stock worth $36,000 after acquiring an additional 153 shares in the last quarter. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on ZTS shares. JPMorgan Chase & Co. lifted their price target on Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Leerink Partnrs raised Zoetis to a “strong-buy” rating in a report on Monday, December 2nd. Leerink Partners began coverage on shares of Zoetis in a report on Monday, December 2nd. They issued an “outperform” rating and a $215.00 price target on the stock. UBS Group began coverage on shares of Zoetis in a research report on Monday, December 9th. They issued a “neutral” rating and a $196.00 price objective for the company. Finally, Stifel Nicolaus decreased their target price on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a report on Tuesday. One analyst has rated the stock with a hold rating, nine have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, Zoetis currently has an average rating of “Buy” and a consensus price target of $211.89.

Zoetis Price Performance

NYSE:ZTS traded down $1.39 during midday trading on Friday, hitting $163.63. The company had a trading volume of 1,094,159 shares, compared to its average volume of 2,169,563. The company has a market capitalization of $73.82 billion, a PE ratio of 30.76, a P/E/G ratio of 2.91 and a beta of 0.89. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26. Zoetis Inc. has a 52-week low of $144.80 and a 52-week high of $200.53. The stock’s fifty day moving average price is $172.08 and its 200-day moving average price is $180.20.

Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Monday, November 4th. The company reported $1.58 EPS for the quarter, beating the consensus estimate of $1.46 by $0.12. The firm had revenue of $2.40 billion for the quarter, compared to analyst estimates of $2.29 billion. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. The company’s revenue was up 11.6% on a year-over-year basis. During the same period in the prior year, the company earned $1.36 EPS. As a group, research analysts expect that Zoetis Inc. will post 5.9 earnings per share for the current year.

Zoetis Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 4th. Stockholders of record on Tuesday, January 21st will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.22%. This is a positive change from Zoetis’s previous quarterly dividend of $0.43. The ex-dividend date of this dividend is Tuesday, January 21st. Zoetis’s payout ratio is presently 37.59%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.